|04-16-2018 05:16 PM CET - Health & Medicine||
Atrial Fibrillation Market to Register 11.0% CAGR During the Forecast Period 2017-2026
Press release from: Transparency Market Research
Atrial fibrillation is an irregular heartbeat identified by the rapid and abnormal beating of the heart. The global market for atrial fibrillation is majorly driven by the rise in high blood pressure and valvular heart disease. Meanwhile, increasing prevalence of atrial fibrillation among the geriatric population is also fueling the growth of the market. Significant technological advancement is leading to the development of new monitoring technologies that can help patients as well as clinicians to keep a close watch and treat it on time. Smart, wireless, easy-to-use, cost-effective, and efficient monitoring systems are also being focused on to monitor the heartbeat. These developments present a major opportunity for key players operating in atrial fibrillation space.
Download Report Brochure @ www.transparencymarketresearch.com/sample/sample.php?flag...
Innovative technologies with the ability to target the causes of atrial fibrillation have led to the maximum success rate of treating the condition. The key market players are also entering into a partnership with research institutes and other companies to develop an efficient system to detect and treat atrial fibrillation.
The research is based on primary and secondary research, done for understanding the trends, drivers, opportunity, restraints, etc. The research is done to forecast the expected revenue of the global atrial fibrillation market. Primary research is based on the information collected from interviews and discussions with a number of industry experts and opinion leaders.
Secondary research includes the study of company websites, press releases, annual reports, investor and analyst presentation, and various other factors. The report also offers an estimated market size in terms of US$ Mn for product type, end-user, and application for the forecast period of 2017 to 2026. The report also takes into account the macro and micro factors that are affecting the market. The report also offers Porter’s five force analysis and SWOT analysis. An in-depth analysis of factors resulting in driving and restraining growth of the market and future opportunities has been provided in the report. The report also offers market attractiveness analysis that provides an analysis of the competitive scenario in the global atrial fibrillation market.
Enquiry for discount on this report @ www.transparencymarketresearch.com/sample/sample.php?flag...
The global atrial fibrillation market is segmented on the basis of product type, end user, and application. Based on the product type, the market is segmented into EP diagnostic catheters, EP ablation catheters, cardiac monitors, EP mapping & recording systems, LAA closure, access devices, and other products. On the basis of end user, the market is segmented on the basis of hospitals, ambulatory surgical center, and electrophysiology labs. By application type, the market includes EP ablation, diagnostic, and surgical. The market growth rate for each segment within the global atrial fibrillation market has been provided after an in-depth research on past trends, future trends demographics, various regulatory requirements, and technological developments.
On the basis of region, the market is segmented on the basis of North America, Europe, Latin America, Asia Pacific Excluding Japan (APEJ), Japan, and the Middle East and Africa (MEA). The forecast for each region has been provided for the year 2017-2026, on the basis of product type, end user, and application. The report also provides revenue share and CAGR in form of percentage for each segment.
The report provides market share analysis of the key players in the global atrial fibrillation market. The report also offers in-depth information for new entrants and established players to expand geographically and also increase their revenue share. Some of the key players in the report include Biosense Webster, Inc., Abbott Laboratories, Medtronic Plc, Boston Scientific Corporation, MicroPort Scientific Corporation, Biotronik SE & Co. KG, Koninklijke Philips N.V., AtriCure Inc., CardioFocus, Inc., and Osypka AG.
Request for Sample Copy of Report @ www.transparencymarketresearch.com/sample/sample.php?flag...
Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.
Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through adhoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.
TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
USA - Canada Toll Free: 866-552-3453
This release was published on openPR.
News-ID: 1018519 • Views: 147More releases